Cerus (CERS) Stock: Buy, Sell, or Hold?
$1.97
-0.16 (-7.31%)
▼
5d:
-7.75%
30d:
-12.28%
90d:
-34.06%
QUANTITATIVE VERDICT
WAIT
LOW Confidence (74%)
Quality Score
49/100
Position
OVERSOLD
30-Day Fair Range
$2.15 – $2.39
Position: OVERSOLD
Forward P/E & Valuation
141.3x
STRETCHED
vs 87.4x historical avg
Wall Street Target
$5.13
+141.7% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$1.91 / $2.52
Trend: Strong Downtrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
📊 MIXED SIGNALS: CERS shows conflicting indicators. Wait for confirmation before entering.
Get Alerted When CERS Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
In-depth Analysis How we analyze
Valuation Analysis: CERS is currently trading at $1.97, which is considered oversold relative to its 30-day fair value range of $2.15 to $2.39. From a valuation perspective, the stock is trading at a premium (Forward PE: 141.3) compared to its historical average (87.4). At these levels, the market is pricing in 17.4% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, CERS is in a strong downtrend. The price is currently testing key support at $1.91. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 7.3% recently.
Market Sentiment: The stock scores a mixed 48/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $5.12 (+141.7%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, CERS is in a strong downtrend. The price is currently testing key support at $1.91. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 7.3% recently.
Market Sentiment: The stock scores a mixed 48/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $5.12 (+141.7%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$2.15 -
$2.39
Company Quality Score
49/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
73.8%
Trading Range & Key Levels
30-Day Trading Range
$2.15 -
$2.39
Current vs Trading Range
OVERSOLD
Support Level
$1.91
Resistance Level
$2.52
Current Trend
Strong Downtrend
Technical data as of
Nov 12, 2026
Quantitative Signal Breakdown
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (48/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-7.3%)
- BULLISH: Trading 141.7% below Wall St target ($5.12)
- NEUTRAL: Trading at premium valuation - market expects 17.4% growth which is achievable
- WARNING: Composite score 49/100 in the bottom quintile — this cohort historically lags the market
Fundamental Context
Forward P/E (Next Year Est.)
141.33
Wall Street Target
$5.13
(+141.7%)
Revenue Growth (YoY)
9.5%
Profit Margin
-3.2%
Valuation Premium vs History
+17.4% premium
PE vs Historical
141.3 vs 87.4
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+17.4%
(market-implied from PE analysis)
1-Year Target
$2.49
(+17%)
2-Year Target
$2.92
(+38%)
3-Year Target
$3.43
(+62%)
3-Yr Target (if PE normalizes)
(PE: 141→87)
PE COMPRESSION
$2.12
(+0%)
Earnings growth offset by PE compression
Share CERS Analysis
Share this live CERS analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (CERS)
Bullish
2 Retail Mentions
Reddit / WSB Comments
1
Bullish
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Nov 3, 2026
Daily AI digest
AI Retail Discussion Summary:
Bullish sentiment on $CERS is driven by strong growth, potential for 2-3x TAM increase, and a cheap valuation. The latest article highlights Cerus's shift to higher-margin kit distribution, successful red blood cell trial, and a nationwide distribution agreement with Blood Centers of America.
Key Retail Themes:
Strong growth
Expanding market opportunities
Shift to higher-margin distribution
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 12, 2026 2:29 PM ET
Data refreshes hourly during market hours. Next update: 3:29 PM
Data refreshes hourly during market hours. Next update: 3:29 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CERS showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
SYK
Stryker Corporation |
STRONG BUY
30 analysts |
$340 | 45 HOLD |
|
BSX
Boston Scientific Corp |
BUY
31 analysts |
$50 | 51 HOLD |
|
MDT
Medtronic PLC |
BUY
30 analysts |
$105 | 41 HOLD |
|
IRTC
iRhythm Technologies Inc |
STRONG BUY
16 analysts |
$166 | 54 HOLD |
|
PODD
Insulet Corporation |
BUY
26 analysts |
$178 | 40 HOLD |
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive CERS Research Pages
